SC 13D

Company

ORAMED PHARMACEUTICALS INC.

Filed

December 15, 2014

Accession Number

0001178913-14-003882

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →